Novel molecular mechanisms inform targeted therapies for chronic kidney disease
A recent study led by Paul DeCaen, Ph.D., associate professor of Pharmacology, has identified novel molecular mechanisms by which genetic mutations in the PKD2 gene cause the most common form…